177.11USD-1.91%Mkt Cap: 17.81B $P/E: 27.25Today
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products i…
Industry Peers
Drug Manufacturers - Specialty & Generic$66.02BUSDP/E 23.9
$23.22BUSDP/E 20.2
$18.95BUSD
$15.65BUSDP/E 179.2
$14.61BUSDP/E 30.6
$12.40BUSD
$8.81BUSDP/E 22.5
$7.96BUSD
$6.93BUSDP/E 458.4
$6.88BUSDP/E 25.2
$5.43BUSDP/E 46.0
$3.62BUSDP/E 18.9
$3.62BUSDP/E 11.6
$3.11BUSDP/E 21.7
$2.81BUSD
$2.66BUSDP/E 59.2
$2.66BUSD
$2.45BUSDP/E 17.0
$2.32BUSDP/E 12.5
$1.89BUSDP/E 19.2
$1.98BUSD
$1.73BUSD
$1.87BUSDP/E 21.0
$1.84BUSD
$1.51BUSDP/E 17.9
$1.58BUSD
$1.44BUSDP/E 119.1
$1.30BUSDP/E 13.8
$1.13BUSDP/E 35.5
$1.14BUSDP/E 17.1
$1.24BUSD
$1.08BUSD
$1.06BUSDP/E Infinity
$954.76MUSD
$1.00BUSD
$1.00BUSDP/E 196.0
$909.64MUSDP/E 39.7
$897.12MUSDP/E 14.4
$825.42MUSDP/E 11.3
$819.46MUSDP/E Infinity
$735.82MUSDP/E 7.2
$700.70MUSDP/E 163.3
$513.32MUSDP/E 14.5
$516.92MUSD
$462.55MUSD
$435.30MUSD
$447.39MUSD
$415.35MUSD
$375.56MUSD
$347.96MUSD
$319.75MUSDP/E 43.6
$308.82MUSD
$316.76MUSDP/E 10.1
$337.92MUSD
$293.86MUSDP/E 15.2
$278.44MUSDP/E 50.0
$287.37MUSD
$250.29MUSDP/E 47.6
$257.49MUSDP/E 12.8
$234.61MUSDP/E 52.6
$207.57MUSD
$194.14MUSDP/E 9.7
$190.26MUSD
$178.17MUSD
$177.48MUSDP/E 8.5
$174.12MUSD
$146.74MUSDP/E 18.7
$151.86MUSD
$130.47MUSD
$140.45MUSD
$120.89MUSD
$120.49MUSDP/E 18.7
$98.17MUSD
$84.56MUSDP/E 12.1
$88.85MUSD
$77.95MUSD
$74.40MUSD
$75.77MUSD
$65.95MUSDP/E 55.6
$65.40MUSD
$64.17MUSDP/E 22.0
$64.25MUSD
$57.58MUSD
$58.28MUSD
$53.33MUSD
$42.74MUSD
$46.21MUSD
$34.09MUSDP/E Infinity
$31.75MUSD
$31.25MUSD
$25.24MUSD
$24.15MUSD
$23.15MUSDP/E 200.0
$23.21MUSD
$22.14MUSD
$22.15MUSD
$17.93MUSD
$17.65MUSD
$14.93MUSD
$14.03MUSDP/E 17.1
$14.08MUSD
$12.18MUSD
$10.87MUSD
$10.99MUSD
$8.99MUSD
$8.90MUSD
$8.27MUSDP/E 0.3
$8.06MUSD
$6.48MUSDP/E 3.9
$6.29MUSD
$6.03MUSD
$5.08MUSDP/E Infinity
$3.29MUSDP/E 1.4
$1.87MUSD
$1.82MUSD
$1.71MUSDP/E 29.2
$1.54MUSD
$668.8KUSD
$207.6KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap17.81B $
Enterprise Value17.30B $
Revenue (TTM)3.10B $
Gross Profit2.81B $
Net Income (TTM)478.60M $
Revenue/Share31.12 USD
Last Price177.11 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees2.0K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS64125C1099
Valuation
P/E (Trailing)27.25
P/E (Forward)14.37
PEG0.50
EV/EBITDA20.88
EV/Revenue5.58
P/S5.85
P/B5.33
EPS (TTM)6.50
EPS (Forward)12.57
52W Range
122.1493% of range181.18
52W High181.18 USD
52W Low122.14 USD
Profitability
Gross Margin98.18%
Oper. Margin22.84%
EBITDA Margin26.71%
Profit Margin16.73%
ROE14.71%
ROA10.33%
Growth
Revenue Growth42.20%
Earnings Growth2310.50%
Cash Flow & Leverage
Operating CF782.70M $
CapEx (TTM)34.00M $
FCF Margin19.04%
FCF Yield3.32%
Net Debt-852.70M $
Net Debt/EBITDA-1.03
Balance Sheet
Debt/Equity0.13
Current Ratio2.93
Quick Ratio2.51
Book Value/Sh33.87 USD
Cash/Share13.09 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateDec 29, 1995
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)197.95 USD
Upside (mean)+11.8%
Target Range144.00 USD – 250.65 USD
$144.00+11.8% to mean$250.65
# Analysts27
Ownership
Shares Out.100.55M
Float99.30M
Insiders1.08%
Institutions104.11%
Short Interest
Short Ratio5.0d
Short % Float7.37%
Short % Out.5.66%
Shares Short5.69M
Short (prev mo.)5.16M
Technical
SMA 50158.01 (+12.1%)
SMA 200143.10 (+23.8%)
Beta0.39
S&P 52W Chg20.11%
Avg Vol (30d)1.03M
Avg Vol (10d)1.16M
Technical Indicators
RSI (14)66.7
MACD5.5868
MACD Signal4.5987
MACD Hist.+0.9882
BB Upper180.86 USD
BB Middle166.41 USD
BB Lower151.96 USD
BB Width17.36%
ATR (14)4.742 USD
Vol Ratio (20d)0.90x